申请人:East China University Of Science And Technology
公开号:EP3312180A1
公开(公告)日:2018-04-25
The present invention relates to a pteridinone derivative serving as an EGFR inhibitor and use thereof. Specifically, the present invention relates to a compound represented by the following formula I, pharmaceutical composition comprising the compound of the following formula I, and use of the compound in preparation of drugs for treating EGFR-mediated diseases or inhibiting EGFR.
本发明涉及一种作为表皮生长因子受体抑制剂的蝶啶酮衍生物及其用途。具体地说,本发明涉及由下式I代表的化合物、包含下式I化合物的药物组合物,以及该化合物在制备治疗表皮生长因子受体介导的疾病或抑制表皮生长因子受体的药物中的用途。